These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 865367)

  • 1. The management of febrile episodes in-neutropenic cancer.
    Bishop JF; McLennan R; Whiteside MG
    Med J Aust; 1977 Apr; 1(14):473-5. PubMed ID: 865367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of granulocyte transfusions for infection in acute leukemia.
    Alavi JB; Root RK; Djerassi I; Evans AE; Gluckman SJ; MacGregor RR; Guerry D; Schreiber AD; Shaw JM; Koch P; Cooper RA
    N Engl J Med; 1977 Mar; 296(13):706-11. PubMed ID: 320477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of infections in immunocompromised cancer patients.
    Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S
    Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936
    [No Abstract]   [Full Text] [Related]  

  • 4. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
    Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
    J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
    Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
    Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric therapy of febrile granulocytopenic patients.
    Hopefl AW
    Am J Hosp Pharm; 1979 Feb; 36(2):178-87. PubMed ID: 369364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial infections in low-risk, febrile neutropenic patients.
    Kamana M; Escalante C; Mullen CA; Frisbee-Hume S; Rolston KV
    Cancer; 2005 Jul; 104(2):422-6. PubMed ID: 15937905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobramycin and cephalothin for treatment of suspected sepsis in neutropenic children with cancer.
    Cohen JD; Miale TD
    J Infect Dis; 1976 Aug; 134 Suppl():S175-7. PubMed ID: 972278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte transfusions as a therapy and a prophylaxis of infections in neutropenic patients.
    Klastersky J
    Eur J Cancer (1965); 1979; 15 Suppl():15-22. PubMed ID: 397059
    [No Abstract]   [Full Text] [Related]  

  • 10. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview.
    Lieschke GJ; Bell D; Rawlinson W; Green MD; Sheridan W; Morstyn G; Stuart-Harris R; Kefford RF; Levi J; Sorrell T
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S37-42. PubMed ID: 2693108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low morbidity and mortality from infection in neutropenic patients, a possible result of multiple measures of infection prevention.
    Grob JP; Francioli P; Pécoud A; Glauser MP
    Schweiz Med Wochenschr Suppl; 1983; 14():70-5. PubMed ID: 6581532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of 315neutropenic febrile episodes in a cancer center].
    Dutronc H; Billhot M; Dupon M; Eghbali H; Donamaria C; Dauchy FA; Reiffers J
    Med Mal Infect; 2009 Jun; 39(6):388-93. PubMed ID: 19062208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.
    Feld R; Louie TJ; Mandell L; Bow EJ; Robson HG; Chow A; Belch A; Miedzinski L; Rachlis A; Pater J
    Arch Intern Med; 1985 Jun; 145(6):1083-8. PubMed ID: 3890789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of infections in granulocytopenic patients with granulocyte transfusions.
    Mód A; Harsányi V; Jakschitz M; Hollán SR
    Haematologia (Budap); 1977; 11(1-2):31-40. PubMed ID: 352851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.
    Shenep JL
    NCI Monogr; 1990; (9):117-22. PubMed ID: 2342588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of teicoplanin in neutropenic patients: values and limits].
    Espinouse D; Chomarat M
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperacillin and gentamicin as non toxic empirical therapy in pediatric patients with fever and neutropenia.
    González M; Clavell LA
    P R Health Sci J; 1987 Apr; 6(1):13-5. PubMed ID: 3615796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early granulocyte transfusions in high risk febrile neutropenic patients.
    Schweiz Med Wochenschr Suppl; 1983; 14():46-8. PubMed ID: 6361991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Empiric therapy with piperacillin plus amikacin for febrile patients with cancer--with emphasis on granulocytopenia].
    Sampi K; Kumai R; Sakurai M; Kaneko Y; Hattori M
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1301-5. PubMed ID: 4004291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical antibiotics for febrile neutropenic cancer patients.
    Hathorn JW
    Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.